$Johnson & Johnson(JNJ)$ paid $14.6 billion for Intra-Cellular Therapies to make Caplyta a central neuroscience asset. Positive bipolar-mania data now broaden the potential return on that purchase, but one successful trial does not yet create an approved indication. J&J announced on September 21 that a pivotal Phase 3 study met its primary endpoint in adults with manic episodes associated with bipolar I disorder. Caplyta produced a 4.8-point greater reduction than placebo on the Young Mania Rating Scale at week three, with improvement observed from day three. Clinical response, defined in the study as at least a 50% score reduction, occurred in 45.8% of Caplyta patients versus 20.9% on placebo. J&J's official study announcement provides

Option C

Last week, we put on a very small straddle position in QQQ: we simultaneously bought a September 25 call and put, both with a strike price of 704. The two legs cost $9.73 and $8.93, respectively. A few trading days later, the call has risen to $37.74, generating an unrealized gain of $2,800, while the put has fallen to just $0.26, producing a loss of $867. Netting the two together, this lightly sized position has already doubled. $纳指100ETF(QQQ)$ $纳斯达克(.IXIC)$ $NQ100指数主连 2609(NQmain)$ $微型NQ100指数主连 2609(MNQmain)$

For me, AI Compute & Infrastructure remains the most interesting theme. AMD, $Cloudflare, Inc.(NET)$ and $F5 Inc(FFIV)$ show that AI growth is expanding beyond GPUs into networking, security and application delivery. I am especially watching AMD because of its strong data-center growth, although expectations are also much higher now. That said, I do not think this rally is purely about AI. CRWD and RBRK highlight rising cybersecurity demand, while VLO and MPC benefit from different energy and refining catalysts. I like seeing broa

I’d choose B — Cybersecurity & Data Resilience. The deeper story here is that AI doesn’t just create demand for more compute; it also expands the attack surface and increases the value of protecting data. That makes cybersecurity less of a “side trade” to AI and more of an infrastructure layer supporting its adoption. CRWD stands out because its record $333M net-new ARR, up 51% YoY, points to strong enterprise demand. RBRK offers a different angle: as companies deploy more AI, data recovery and cyber resilience become increasingly important. What makes this theme interesting is its potential durability. Compute spending can be cyclical, but once AI becomes embedded in business operations, security and data protection become increasingly difficult to cut. For me, the key question is no

$IX Biopharma(42C.SI)$ $0.8 Target Price. --Ix Biopharama Medical Breakthrough-- iX Biopharma achieved a major medical and commercial breakthrough with Wafermine, its patented sublingual (under-the-tongue) ketamine wafer for non-opioid acute pain management. --The Core Technology-- WaferiXFast Absorption: Wafers dissolve sublingually in minutes, letting active ingredients enter the bloodstream directly and bypass the gut. High Bioavailability: Provides a needle-free, predictable alternative to intravenous infusions or standard oral pills. Drug Repurposing: Applies the delivery system to central nervous system agents and other urgent indications. --Key Pipeline & Commercial Milestones-- Backed by a US$40.95 million contract from the US Depar

I’m watching the shift beyond mega-cap tech. AI infrastructure and cybersecurity still stand out, but energy and healthcare are showing that market leadership is becoming more diversified. 👀 From the list, $CRWD is the one I’d keep on the watchlist — curious to see whether cybersecurity momentum can continue.

For my answer: B — Cybersecurity & Data Resilience. Why? AI is growing fast, but it also creates more cyber risks. CRWD has strong ARR growth and rising customer demand. RBRK is growing quickly and focuses on data protection and ransomware recovery. AI agents and companies using more AI will need more security and data protection. A (AI) is also very strong, especially AMD, but valuations are already high after the big rally. C (Energy) can benefit from oil-supply problems, but this may be more cyclical and temporary. D (Healthcare/Financials) looks more defensive, with steadier growth but less explosive potential. Bottom line: For the next 1–3 years, I would watch B: cybersecurity + data resilience closely. The key is: AI growth → more data → more cyber risk → more securit

U.S. stocks rallied significantly on Monday, September 21, 2026, driven by falling oil prices, retreating Treasury yields, and a surge in artificial intelligence and semiconductor heavyweights. In this article, we would like to look at the macro drivers (which is the catalyst trinity), look at a comprehensive sector by sector performance, we will be also looking at key individual stock movers and corporate catalysts, semiconductor architecture and AI supply chain dynamics, fixed income, commodities and currency dynamics and market outlook and institutional positioning. I am holding these tech stocks comprising of semiconductors, memory and software. 1. MACRO DRIVERS: THE CATALYST TRINITY Monday’s market action represented a classic "risk-on" impulse fueled by a simultaneous unwinding of in

$First Resources(EB5.SI)$ 5.8 Target Price. First Resources (EB5.SI) is experiencing a powerful upswing driven by a 53.1% YoY surge in Q1-2026 net profit, fueled by record-high sales volumes and a favorable palm oil pricing environment. While the stock has rallied sharply, leading to what some analysts see as fair valuation. The biofuels underlying business momentum remains robust, with supportive macroeconomic from fluctuating oil prices, caused by Hormuz-Strait blockage. Growth Catalysts 1. Exceptional Q1 2026 Financial Performance The company's recent quarterly report shows a dramatic acceleration in growth. Revenue: Sales surged 70.4% year-on-year (YoY) to US$477.2 million in Q1-2026. Net Profit: Net profit attributable to biofuels demands j

📈 I don’t chase the market when everything is flying. When the major indexes are near all-time highs, I know it can be tempting to jump into whatever is already running. But that is not how I like to invest. My Options Puppy approach is simple: when the market becomes expensive and crowded, I start looking for the stocks and ETFs that have been rotated out of instead. 🐶💰 🔄 What does “rotated out” mean? It simply means investors have moved money away from a particular stock, sector or ETF and into another part of the market. It does not automatically mean the stock is cheap or that it will rebound. Sometimes investors rotate out because the business has genuine problems. My job is therefore not to blindly buy the loser. My job is to ask: “Has the price fallen more than the underlying busine

I’m watching something much more boring today: $AutoZone(AZO)$  $AZO is reporting earnings today, putting the auto-parts retailer directly in the spotlight.  Why is this interesting? Because AutoZone can give us another read on the U.S. consumer. When people keep older cars instead of buying new ones, repairs and maintenance can become more important. At the same time, inflation and household budgets are forcing consumers to think harder about where they spend. So the questions I’m watching tonight: 🔧 Are DIY customers still spending? 🚗 Is demand for vehicle maintenance holding up? 💰 How are margins dealing with cost pressure? 📈 What does management say about the consumer? The stock is also trading near recent lows, so expectations matter. A

AI stocks are rallying again. But there’s another trade quietly getting interesting: cybersecurity. $CrowdStrike Holdings, Inc.(CRWD)$  jumped around 4% Monday as investors focused on the growing security risks created by increasingly capable AI systems.  The interesting part? AI doesn’t just create productivity. It also gives attackers more powerful tools. That could mean more demand for: 🔐 Endpoint protection 🤖 AI-driven threat detection 🪪 Identity security ⚡ Faster automated response CrowdStrike sits directly in the endpoint-security layer, making it one of the names I’m watching as the AI adoption story expands beyond chips and data centres. But there’s a catch: today’s move is based largely on expectations, not a sudden change in r

$迈威尔科技(MRVL)$  

$SpaceX(SPCX)$ nasa announcement on more flights movement likely

# A Cleaner Tech Setup, With One Yield Risk The market has spent a lot of energy going almost nowhere. I find that frustrating when I am looking for a clean directional move, but it is also a useful reminder to judge the structure rather than react to every red day. The broad index tested support, briefly slipped below a familiar moving average, and recovered. That does not make the next move certain. It does keep me from declaring the bullish case broken too early. I am treating the new setups I review today as ideas to evaluate, not orders I have placed. Technology is where the chart looks most interesting to me. Semiconductor shares have leaned on the same support repeatedly, yet that level has held so far. I would still like to see follow-through rather than assume one good close settl

$Advanced Micro Devices(AMD)$  How high can it go! 

The Treasury Operation That Ate the Software Company At $153.92 on 18 September 2026, $Strategy(MSTR)$ carries a market capitalisation of $59.14 billion against trailing revenue of just $498.35 million. That gap is not necessarily a problem; it is the point. Investors are valuing Strategy less as a software company and more as a capital-markets vehicle built around Bitcoin, with digital assets carried at $49.67 billion at 30 June. I find it fascinating in the way a Rube Goldberg machine is fascinating: ingenious, elegant and slightly alarming once you count how many things need to go right. The question is whether it keeps creating value for common shareholders once the cost of maintaining it is properly counted. The software company became a mach